News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,235 Results
Type
Article (6776)
Company Profile (39)
Press Release (86420)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (27786)
Career Advice (127)
Deals (4002)
Drug Delivery (32)
Drug Development (14141)
Employer Resources (12)
FDA (2868)
Job Trends (2121)
News (49333)
Policy (6032)
Tag
2024 BioForest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (429)
Accelerated approval (3)
Adcomms (7)
Allergies (32)
Alliances (9025)
ALS (13)
Alzheimer's disease (264)
Antibody-drug conjugate (ADC) (45)
Approvals (2865)
Artificial intelligence (46)
Autoimmune disease (9)
Automation (3)
Bankruptcy (19)
Best Places to Work (1805)
BIOSECURE Act (16)
Biosimilars (77)
Biotechnology (26)
Bladder cancer (22)
Brain cancer (6)
Breast cancer (53)
Cancer (467)
Cardiovascular disease (22)
Career advice (111)
Career pathing (3)
CAR-T (21)
Cell therapy (84)
Cervical cancer (3)
Clinical research (11547)
Collaboration (194)
Compensation (43)
Complete response letters (9)
COVID-19 (545)
CRISPR (5)
C-suite (52)
Cystic fibrosis (13)
Data (441)
Denatured (2)
Depression (6)
Diabetes (36)
Diagnostics (559)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (26)
Drug pricing (24)
Drug shortages (1)
Duchenne muscular dystrophy (26)
Earnings (9533)
Editorial (6)
Employer branding (3)
Employer resources (10)
Events (11900)
Executive appointments (123)
FDA (3215)
Featured Employer (9)
Frontotemporal dementia (1)
Funding (148)
Gene editing (24)
Generative AI (6)
Gene therapy (85)
GLP-1 (109)
Government (1325)
Grass and pollen (1)
Guidances (12)
Healthcare (1952)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (43)
Indications (9)
Infectious disease (581)
Inflammatory bowel disease (47)
Inflation Reduction Act (4)
Influenza (15)
Intellectual property (12)
Interviews (11)
IPO (1840)
IRA (13)
Job creations (385)
Job search strategy (107)
Kidney cancer (2)
Labor market (2)
Layoffs (55)
Leadership (1)
Legal (562)
Liver cancer (13)
Lung cancer (76)
Lymphoma (29)
Machine learning (1)
Management (2)
Manufacturing (113)
MASH (12)
Medical device (1170)
Medtech (1171)
Mergers & acquisitions (2261)
Metabolic disorders (87)
Multiple sclerosis (18)
NASH (2)
Neurodegenerative disease (18)
Neuropsychiatric disorders (1)
Neuroscience (341)
NextGen: Class of 2025 (699)
Non-profit (349)
Northern California (484)
Now hiring (11)
Obesity (32)
Opinion (48)
Ovarian cancer (20)
Pain (9)
Pancreatic cancer (13)
Parkinson's disease (9)
Partnered (3)
Patents (32)
Patient recruitment (19)
Peanut (21)
People (8010)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase I (3799)
Phase II (4800)
Phase III (4238)
Pipeline (303)
Policy (51)
Postmarket research (300)
Preclinical (1480)
Press Release (66)
Prostate cancer (19)
Psychedelics (5)
Radiopharmaceuticals (38)
Rare diseases (73)
Real estate (918)
Recruiting (4)
Regulatory (4795)
Reports (11)
Research institute (387)
Resumes & cover letters (11)
RNA editing (1)
RSV (11)
Schizophrenia (11)
Series A (35)
Series B (13)
Service/supplier (3)
Sickle cell disease (7)
Southern California (485)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (577)
State (1)
Stomach cancer (3)
Supply chain (11)
Tariffs (9)
The Weekly (4)
United States (4178)
Vaccines (189)
Venture capitalists (6)
Weight loss (16)
Women's health (3)
Date
Today (24)
Last 7 days (96)
Last 30 days (516)
Last 365 days (6265)
2025 (1939)
2024 (6533)
2023 (6985)
2022 (9083)
2021 (9487)
2020 (8187)
2019 (5853)
2018 (4528)
2017 (5066)
2016 (4620)
2015 (5273)
2014 (3719)
2013 (2899)
2012 (2991)
2011 (3150)
2010 (2573)
Location
Africa (92)
Alabama (11)
Alaska (1)
Arizona (12)
Arkansas (2)
Asia (7541)
Australia (894)
California (1149)
Canada (238)
China (174)
Colorado (33)
Connecticut (26)
Delaware (40)
Europe (13881)
Florida (137)
Georgia (20)
Idaho (13)
Illinois (50)
India (12)
Indiana (40)
Iowa (1)
Japan (30)
Kansas (3)
Kentucky (9)
Louisiana (2)
Maine (5)
Maryland (319)
Massachusetts (795)
Michigan (24)
Minnesota (45)
Mississippi (1)
Missouri (15)
Montana (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (456)
New Mexico (4)
New York (328)
North Carolina (199)
North Dakota (7)
Northern California (484)
Ohio (40)
Oklahoma (7)
Oregon (2)
Pennsylvania (190)
Puerto Rico (1)
Rhode Island (5)
South America (135)
South Carolina (2)
Southern California (485)
Tennessee (3)
Texas (155)
Utah (24)
Virginia (18)
Washington D.C. (6)
Washington State (92)
Wisconsin (8)
93,235 Results for "agc biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AGC Biologics Honored by Customers and Industry Leaders for Excellence in Contract Development and Manufacturing
March 10, 2025
·
2 min read
Press Releases
AGC Biologics Strengthens Single-Use Technology Network and Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility
April 8, 2025
·
3 min read
Press Releases
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
January 10, 2025
·
5 min read
BioForest
AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg
AGC Biologics today announced the completion of the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at the CDMO’s Heidelberg, Germany site.
October 12, 2023
·
3 min read
Drug Delivery
The Next Frontier: Industrializing Cell Therapy Manufacturing
Q&A: Development Scientist at AGC Biologics Sara Morlacchi analyzes the growth of the cell therapy industry and barriers for cost and accessibility.
April 29, 2024
·
7 min read
·
Sara Morlacchi, Cell Process Development Manager, AGC Biologics
BioForest
AGC Biologics Milan Receives Special Award Mention by Confindustria for Research and Innovation
AGC Biologics announced that the team at its Milan site has received a special mention for Research and Innovation led by Executives Under the Age of 40, one of six special mentions in the Business Prize for Innovation by Confindustria.
November 1, 2023
·
2 min read
Business
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization, announced a new agreement with Asahi Kasei Pharma Corporation to produce clinical drug substance for antibody-based therapies at AGC Biologics’ Seattle manufacturing site.
August 15, 2023
·
2 min read
BioForest
AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Product
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization, announced a new service agreement with Medigene AG.
October 25, 2023
·
3 min read
BioForest
AGC Biologics Received Bioprocessing Excellence Award in Japan
AGC Biologics announced it has received the “Bioprocessing Excellence in Japan” award at the Asia-Pacific Bioprocessing Excellence Awards ceremony for the work and achievements at the AGC Biologics Chiba, Japan site.
April 25, 2023
·
3 min read
BioForest
AGC Biologics Expands Cell Therapy Suites at Longmont ATMP Campus
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization, announced a capacity update with the addition of three new Grade B cell therapy suites to its Longmont, CO facility.
August 23, 2023
·
3 min read
1 of 9,324
Next
